TITLE

Cancer screening in a middle-aged general population: factors associated with practices and attitudes

AUTHOR(S)
Cullati, Stéphane; Charvet-Bérard, Agathe I.; Perneger, Thomas V.
PUB. DATE
January 2009
SOURCE
BMC Public Health;2009, Vol. 9, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The aim of this study was to identify factors associated with cancer screening practices and with general attitudes toward cancer screening in a general population. Methods: Mailed survey of 30-60 year old residents of Geneva, Switzerland, that included questions about screening for five cancers (breast, cervix uteri, prostate, colon, skin) in the past 3 years, attitudes toward screening, health care use, preventive behaviours and socio-demographic characteristics. Cancer screening practice was dichotomised as having done at least one screening test in the past 3 years versus none. Results: The survey response rate was 49.3% (2301/4670). More women than men had had at least one cancer screening test in the past 3 years (83.2% vs 34.5%, p < 0.001). A majority of women had had a cervical smear (76.6%) and a mammography (age 30-49: 35.0%; age 50 and older: 90.3%); and 55.1% of men 50-60 years old had been screened for prostate cancer. Other factors associated with screening included older age, higher income, a doctor visit in the past 6 months, reporting a greater number of preventive behaviours and a positive attitude toward screening. Factors linked with positive attitudes included female gender, higher level of education, gainful employment, higher income, a doctor visit in the past 6 months and a personal history of cancer. Conclusion: Attitudes play an important role in cancer screening practices among middle-aged adults in the general population, independent of demographic variables (age and sex) that determine in part screening recommendations. Negative attitudes were the most frequent among men and the most socio-economically disadvantaged. The moderate participation rate raises the possibility of selection bias.
ACCESSION #
43226979

 

Related Articles

  • Socio-demographic characteristics of participation in the opportunistic German cervical cancer screening programme: results from the EPIC-Heidelberg cohort. Seidel, David; Becker, Nikolaus; Rohrmann, Sabine; Nimptsch, Katharina; Linseisen, Jakob // Journal of Cancer Research & Clinical Oncology;Apr2009, Vol. 135 Issue 4, p533 

    To analyse participation in the German cervical cancer screening programme by socio-demographic characteristics. In the EPIC-Heidelberg cohort study 13,612 women aged 35–65 years were recruited between 1994 and 1998. Follow-up questionnaires were used to analyse participation in cervical...

  • PREVALENCE AND IMPACT OF CERVICAL HPV INFECTIONS IN TAIWAN. Tang-Yuan Chu // Infectious Diseases in Obstetrics & Gynecology;2006, Vol. 2006, p22 

    Taiwan's national cervical screening programme In 1988-1992, the AAR of cervical cancer in Taiwan (22.2/ 100 000) was higher compared with other Asian nations with Chinese populations, such as Singapore (16.3/100 000) and Hong Kong (15.3/100 000). In 1995, Taiwan instituted the National Cervical...

  • Behind the headlines: Do cervical screening benefits outweigh the risks? Ellul, Joanne // GP: General Practitioner;8/7/2009, p14 

    The article focuses on the study conducted by the Researchers from Queen Mary University, London, England. The study found that screening women between the ages of 30 and 37 was related to reduction in cancer risk of 43-60 per cent over the next five years. The study however found no evidence...

  • Women' perspectives on illness when being screened for cervical cancer. Hounsgaard, Lise; Augustussen, Mikaela; Møller, Helle; Bradley, Stephen K.; Møller, Suzanne // International Journal of Circumpolar Health;2013, Vol. 72, p1 

    Background. In Greenland, the incidence of cervical cancer caused by human papillomavirus (HPV) is 25 per 100,000 women; 2.5 times the Danish rate. In Greenland, the disease is most frequent among women aged 30-40. Systematic screening can identify women with cervical cell changes, which if...

  • Burden of cervical cancer in Europe: estimates for 2004. M. Arbyn; A. O. Raifu; P. Autier; J. Ferlay // Annals of Oncology;Oct2007, Vol. 18 Issue 10, p1708 

    The European Council recommends that organised cervical cancer screening be offered in all member states. In order to evaluate the impact of existing and new prevention methods, regularly updated information on the burden of cervical cancer is needed. The best estimates of mortality and...

  • Is It Time to Introduce HPV Self-Sampling for Primary Cervical Cancer Screening? Petignat, Patrick; Vassilakos, Pierre // JNCI: Journal of the National Cancer Institute;Feb2012, Vol. 104 Issue 3, p166 

    The author explores the issues surrounding the introduction of human papillomavirus (HPV) self-sampling (Self-HPV) as an alternative means for cervical cancer screening. He discusses factors that may discourage women from going to regular screening. He also suggests fundamental issues that must...

  • Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. Moser, Kath; Patnick, Julietta; Beral, Valerie // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/20/2009, Vol. 338 Issue 7709, p1480 

    Objective To investigate the relation between women's reported use of breast and cervical screening and sociodemographic characteristics. Design Cross sectional multipurpose survey. Setting Private households, Great Britain. Population 3185 women aged 40-74 interviewed in the National Statistics...

  • Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study. Tranberg, Mette; Larsen, Mette Bach; Mikkelsen, Ellen M.; Svanholm, Hans; Andersen, Berit // BMC Public Health;Jul2015, Vol. 15 Issue 1, p1 

    Background: Systematic screening for precancerous cervical lesions has resulted in decreased incidence and mortality of cervical cancer. However, even in systematic screening programs, many women are still tested opportunistically. This study aimed to determine the spread of opportunistic...

  • Is magnification necessary to confirm visual inspection of cervical abnormalities? A randomized trial in Peru. Winkler, Jennifer L.; Lewis, Kristen; Del Aguila, Roberto; Gonzales, Miguel; Delgado, José Manuel; Tsu, Vivien D.; Sellors, John W. // Pan American Journal of Public Health;Jan2008, Vol. 23 Issue 1, p1 

    Objectives. Cervical cancer is the leading cause of cancer death among women in developing countries. This study was designed to evaluate whether visual inspection with acetic acid and magnification (VIAM) improved confirmation of cervical lesions as compared to confirmation with visual...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics